• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

£2.6 million to create new approach to care for the under 40s with type 2 diabetes

Jun 14, 2021

Funding for a five-year project, that aims to develop a new type of care package that addresses gaps in support for people under 40 living with type 2 diabetes, has been awarded to a research team in Leicester.

The £2.6 million project called ‘M3’ is led by Professor Melanie Davies, director of the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) and Leicester Diabetes Centre (LDC), and brings together experts from across the UK and abroad. Researchers will work with patients, healthcare professionals and NHS decision makers to develop the programme.

The news comes ahead of Diabetes Awareness Week (14-20 June). Type 2 diabetes is a condition in which the body struggles to process blood sugar, causing a higher chance of health problems, such as heart attacks and strokes. In the past, type 2 diabetes mostly affected only older adults, but over recent years, the number of people being diagnosed at a younger age has increased.

When type 2 diabetes occurs in people under the age of 40 it is considered ‘early onset’. Early-onset type 2 diabetes often occurs alongside other conditions such as obesity and high blood pressure, as well as mental health problems like anxiety or depression, and is associated with an increased risk of developing harmful health problems over these people’s lives.

People with early-onset type 2 diabetes also often have very different lives and circumstances to older adults. However, existing treatments and programmes to help people self-manage their diabetes have been based on evidence from research studies in older people. A previous Lancet report has highlighted the need to help the growing number of younger people living with diabetes worldwide.

Dr Jack Sargeant, a researcher on the M3 project said: “We often hear that people with early-onset type 2 diabetes struggle to find advice and resources that address the issues they have, whether that’s mental health or family life or something else. By designing this programme with people who live with early onset type 2 diabetes, we will develop the treatment packages that these people need to get the best care possible.”

The project includes an ambitious range of activities to ensure the research is accessible and relevant to people from a variety of backgrounds and circumstances, including people of different ages and ethnicities, and with different working and family circumstances. This work will include a large ‘consensus conference’, where people from different backgrounds and life experiences will come together with the research team and people from the NHS to design the programme collectively.

After the programme has been designed, a clinical trial to test the new approach will run from sites in Leicester, London, Derby, and Liverpool.

Professor Melanie Davies, who is Professor of Diabetes at the University of Leicester, said of the new project: “By hearing from patients and healthcare professionals we hope to create a new type of care to meet the needs of people with early onset type 2 diabetes and improve their wellbeing. We also want to use the very latest technology and approaches to really make a difference.”

If you are under the age of 40, living with type 2 diabetes and would like to get involved in the project, please contact: M3research@uhl-tr.nhs.uk

Ends

Category: Press ReleasesTag: diabetes, lifestyle, News, Press Release, Public Engagement

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}